Tag: generic drugs
Prescribers remain divided on generic substitution of narrow therapeutic index (NTI) drugs like warfarin and levothyroxine. While FDA data supports safety, real-world experience shows risks in stability, monitoring, and communication. State laws, physician preferences, and patient outcomes all shape substitution practices.